Lin Yao, Yang Fanghui, Shang Binghan, Speich John E, Wan Yu-Jui Yvonne, Hashida Hiroki, Braun Tobias, Sadoughi Ali, Puehler Thomas, Lue Tom F, Zhang Kaiping
Editorial Office, AME Publishing Company, Hong Kong, China.
Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University College of Engineering, Richmond, Virginia, USA.
Cardiovasc Diagn Ther. 2024 Dec 31;14(6):1070-1082. doi: 10.21037/cdt-24-413. Epub 2024 Dec 17.
The adherence to the Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines across the journals that initially published the guidelines and if adherence has improved since the guidelines update, remains unknown. We aimed to quantify the level of adherence and analyze factors that might influence reporting quality among these journals.
This cross-sectional study retrospectively analyzed interventional animal experiments published in journals that released ARRIVE 1.0 and 2.0 guidelines in three periods: 5 years before (Pre-ARRIVE 1.0) and after (Post-ARRIVE 1.0) the publication of ARRIVE 1.0, and 1 year after the publication of ARRIVE 2.0 (Post-ARRIVE 2.0). Reviewers independently assessed adherence to the ARRIVE guidelines. Basic information and potential influencing factors were extracted. Adherence data were presented as frequency (percentages). Statistical factors influencing reporting quality were evaluated using the Chi-square test or Fisher's exact test.
215, 330, and 398 experiments were included during Pre-ARRIVE 1.0, Post-ARRIVE 1.0 and Post-ARRIVE 2.0 periods, respectively. None of the included 943 studies reported all 38 subitems, showing only 0%, 0%, and 0.25% studies had an "excellent" reporting quality across the three periods. The overall reporting quality was significantly improved among Pre-ARRIVE 1.0, Post-ARRIVE 1.0 and Post-ARRIVE 2.0 (P<0.001). The rate of studies with "average" reporting quality increased sequentially from 53.95% to 73.94% and then to 90.20%, and those with "poor" reporting quality decreased sequentially from 46.05% to 26.06% and then to 9.55% across the three periods. Specifically, 15 out of 38 (39.5%) subitems and 11 out of 27 (40.7%) similar and comparable subitems demonstrated a significant higher percentage of "fully reported" in Post-ARRIVE 1.0 compared to Pre-ARRIVE 1.0 and in Post-ARRIVE 2.0 compared to Post-ARRIVE 1.0, respectively (P<0.05). Country and journal indexing did not significantly affect reporting quality (both P>0.05). However, significant differences in reporting quality were found among the mandatory adherence to the ARRIVE guidelines in the author's instructions and reference to ARRIVE in the manuscript (both P<0.001).
In the journals that initially published the ARRIVE guidelines, compliance with the guidelines still has room for improvement, though it has increased sequentially since introducing the guidelines. Implementing mandatory adherence requirements in the author's instructions and explicitly recognizing adherence to ARRIVE in articles could enhance the reporting quality of interventional animal experiments.
最初发布《动物研究:体内实验报告规范》(ARRIVE)指南的各期刊对该指南的遵循情况,以及自指南更新后遵循情况是否有所改善,目前尚不清楚。我们旨在量化遵循水平,并分析这些期刊中可能影响报告质量的因素。
这项横断面研究回顾性分析了在三个时期发表于发布ARRIVE 1.0和2.0指南期刊上的干预性动物实验:ARRIVE 1.0发布前5年(ARRIVE 1.0之前)、发布后(ARRIVE 1.0之后),以及ARRIVE 2.0发布后1年(ARRIVE 2.0之后)。评审人员独立评估对ARRIVE指南的遵循情况。提取基本信息和潜在影响因素。遵循数据以频率(百分比)呈现。使用卡方检验或Fisher精确检验评估影响报告质量的统计因素。
在ARRIVE 1.0之前、ARRIVE 1.0之后和ARRIVE 2.0之后时期,分别纳入了215、330和398项实验。纳入的943项研究中没有一项报告了全部38个分项,在三个时期中分别仅有0%、0%和0.25%的研究具有“优秀”的报告质量。在ARRIVE 1.0之前、ARRIVE 1.0之后和ARRIVE 2.0之后,总体报告质量有显著提高(P<0.001)。“中等”报告质量的研究比例在三个时期依次从53.95%增至73.94%,然后增至90.20%,而“差”报告质量的研究比例依次从46.05%降至26.06%,然后降至9.55%。具体而言,与ARRIVE 1.0之前相比,38个分项中的15个(39.5%)以及27个相似且可比分项中的11个(40.7%),在ARRIVE 1.0之后“完整报告”的比例显著更高;与ARRIVE 1.0之后相比,在ARRIVE 2.0之后同样如此(P<0.05)。国家和期刊索引对报告质量没有显著影响(P均>0.05)。然而,在作者指南中对ARRIVE指南的强制遵循情况以及稿件中对ARRIVE的引用方面,报告质量存在显著差异(P均<0.001)。
在最初发布ARRIVE指南的期刊中,尽管自引入指南后遵循情况有所增加,但对指南的遵守仍有改进空间。在作者指南中实施强制遵循要求,并在文章中明确认可对ARRIVE的遵循,可提高干预性动物实验的报告质量。